PS Ratio
N/A
59 min ago
Summary:
Titan Pharmaceuticals price to sales ratio is not available.TTNP PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +6.9% | +6.9% | - |
| 1 m1 month | - | -15.4% | -15.4% | - |
| 3 m3 months | - | -39.2% | -39.2% | - |
| 6 m6 months | - | -37.1% | -37.1% | - |
| ytdytd | - | +1.6% | +1.6% | - |
| 1 y1 year | - | -61.4% | -54.9% | - |
| 5 y5 years | - | -97.9% | -80.1% | - |
TTNP PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | ||||
| 3 y | 3 years | 1191.30 | 36.47 | ||
| 5 y | 5 years | 1191.30 | -60.96 | ||
| alltime | all time | 6250.99 | -60.96 |
Titan Pharmaceuticals PS Ratio History
| Date | Value |
|---|---|
| 2022 | 192.01(+372.8%) |
| 2021 | 40.61(-6.8%) |
| 2020 | 43.58(+26.0%) |
| 2019 | 34.60(+1089.0%) |
| 2018 | 2.91(-97.8%) |
| 2017 | 131.39(+2229.6%) |
| 2016 | 5.64(-59.9%) |
| 2014 | 14.06(+169.9%) |
| 2013 | 5.21(-55.4%) |
| 2012 | 11.68(-30.1%) |
| 2011 | 16.72(+137.5%) |
| 2010 | 7.04(-99.6%) |
| Date | Value |
|---|---|
| 2009 | 1686.58(-47.3%) |
| 2007 | 3202.21(-22.4%) |
| 2006 | 4127.07(+707.1%) |
| 2005 | 511.32(-84.5%) |
| 2004 | 3305.51(+237.7%) |
| 2003 | 978.83(+7008.4%) |
| 2002 | 13.77(-77.0%) |
| 2001 | 59.75(-87.7%) |
| 2000 | 486.46(-44.0%) |
| 1999 | 868.74(+229.0%) |
| 1998 | 264.08(+5874.7%) |
| 1997 | 4.42(-97.8%) |
| 1996 | 196.91 |
FAQ
- What is the all time high PS ratio for Titan Pharmaceuticals?
What is the all time high PS ratio for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high price to sales ratio is 6250.99